Wesper Journal

Transforming Sleep and Metabolic Health with GLP-1 Medications
Discover how Zepbound® (tirzepatide), the first FDA-approved medication for obstructive sleep apnea (OSA) in adults with obesity, is revolutionizing treatment. Combining effective weight management with symptom relief, Zepbound offers a groundbreaking solution that enhances sleep quality, simplifies care pathways, and improves overall health outcomes. Learn more about this transformative advancement in OSA therapy.
Continue reading
Treatment Options for Central Sleep Apnea
Treatment options for Central Sleep Apnea (CSA) primarily include Positive Airway Pressure (PAP) therapies such as CPAP and BiPAP, which assist breathing during sleep. Additional options like supplemental oxygen and innovative techniques such as overdrive atrial pacing or implantable devices...
Continue reading
Sleep’s Role in Defending Against Alzheimer’s
Deep sleep helps protect the brain from Alzheimer's by clearing harmful beta-amyloid deposits. A UC Berkeley study found that better deep sleep improves memory, especially in those at risk for Alzheimer's. Practical steps like consistent sleep schedules and reducing caffeine can enhance deep sleep and potentially prevent cognitive decline.
Continue reading

our research

The Wesper Journal is our weekly publication dedicated to exploring sleep apnea, sleep health, and the latest updates from Wesper. Each edition offers expert insights, practical tips, and valuable resources to help you better understand and improve your sleep, empowering you to take control of your sleep health journey.

Helix Wesper: The Most Advanced Data Analysis Solution
Helix Wesper: The Most Advanced Data Analysis Solution

Completed by Dr. Chelsie Rohrscheibchelsie@wesper.co Jan 06,...

READ
OSA – Missed or Misdiagnosed?
OSA – Missed or Misdiagnosed?

he CDC estimates that nearly 20%...

READ